SCHEMBL22062811

SCHEMBL22062811

c1ccc(-c2c3ccccc3c(-c3ccc4cc(-c5ccc6cc7oc8ccccc8c7cc6c5)ccc4c3)c3ccccc23)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.42
ESR1 P03372 6/20 0.40
ESR2 Q92731 5/20 0.40
HCRTR1 O43613 1/20 0.39
HPGD P15428 3/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
KMT2A Q03164 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
PGR P06401 1/20 0.39
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
PLA2G2A P14555 3/20 0.38
PLA2G4A P47712 3/20 0.38
LMNA P02545 1/20 0.37
CASP3 P42574 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19076440 0.99 AHR (0.41) AHRESR1ESR2HCRTR1HPGD
SCHEMBL17932056 0.98 AHR (0.44) AHRESR1ESR2HCRTR1HPGD
SCHEMBL19109803 0.97 PLA2G2A (0.42) AHRESR1ESR2HCRTR1HPGD
SCHEMBL19109802 0.97 PLA2G2A (0.42) AHRESR1ESR2HCRTR1HPGD
SCHEMBL19076436 0.97 AHR (0.41) AHRESR1ESR2HCRTR1HPGD
SCHEMBL22062813 0.97 AHR (0.41) AHRESR1ESR2HCRTR1HPGD
SCHEMBL22062807 0.97 AHR (0.42) AHRESR1ESR2HCRTR1HPGD
SCHEMBL22063117 0.97 AHR (0.42) AHRESR1ESR2HCRTR1HPGD
SCHEMBL19076337 0.96 AHR (0.40) AHRESR1ESR2HCRTR1HPGD
SCHEMBL19076306 0.96 AHR (0.41) AHRESR1ESR2HCRTR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320251-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE IDEMITSU KOSAN CO.,LTD. (JP) 2021-10-14 US disclosed
US-20200181160-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-06-11 US disclosed
US-20200185620-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320251-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE OLA1, TAS2R19, TMEM109 AHR 1116/4885ESR1 171/4885ESR2 105/4885
US-20200181160-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE AHR, EMC2, NFE2L2 AHR 1/4885ESR1 61/4885ESR2 16/4885
US-20200185620-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE EMC2, NFE2L2, AOC2 AHR 8/4885ESR1 45/4885ESR2 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.